Genomic comparison of Escherichia coli serotype O103:H2 isolates with and without verotoxin genes: implications for risk assessment of strains commonly found in ruminant reservoirs

References

• Croxen MA, Law RJ, Scholz R, Keeney KM, Wlodarska M, Finlay BB. Recent advances in understanding enteric pathogenic Escherichia coli. Clin Microbiol Rev. 2013; 26: 822–80. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Trabulsi LR, Keller R, Tardelli Gomes TA. Typical and atypical enteropathogenic Escherichia coli . Emerg Infect Dis. 8: 508–13.
   Web of Science ®Google Scholar
• Nguyen Y, Sperandio V. Enterohemorrhagic E. coli (EHEC) pathogenesis. Front Cell Infect Microbiol. 2012; 2: 90. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• The National Board of Health and Welfare. Infektion med EHEC/VTEC – Ett nationellt strategidokument. 2014. ISBN 978-91-7555-249-1.
   Google Scholar
• Karch H, Denamur E, Dobrindt U, Finlay BB, Hengge R, Johannes L, etal. The enemy within us: lessons from the 2011 European Escherichia coli O104:H4 outbreak. EMBO Mol Med. 2012; 4: 841–48. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Bielaszewska M, Prager R, Kock R, Mellmann A, Zhang W, Tschape H, etal. Shiga toxin gene loss and transfer in vitro and in vivo during enterohemorrhagic Escherichia coli O26 infection in humans. Appl Environ Microbiol. 2007; 73: 3144–50. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Mellmann A, Lu S, Karch H, Xu JG, Harmsen D, Schmidt MA, etal. Recycling of Shiga toxin 2 genes in sorbitol-fermenting enterohemorrhagic Escherichia coli O157:NM. Appl Environ Microbiol. 2008; 74: 67–72. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• L'Abee-Lund TM, Jorgensen HJ, O'Sullivan K, Bohlin J, Ligard G, Granum PE, etal. The highly virulent 2006 Norwegian EHEC O103:H25 outbreak strain is related to the 2011 German O104:H4 outbreak strain. PloS One. 2012; 7: e31413. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Tozzoli R, Grande L, Michelacci V, Ranieri P, Maugliani A, Caprioli A, etal. Shiga toxin-converting phages and the emergence of new pathogenic Escherichia coli a world in motion. Front Cell Infect Microbiol. 2014; 4: 80. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Muniesa M, Serra-Moreno R, Jofre J. Free Shiga toxin bacteriophages isolated from sewage showed diversity although the stx genes appeared conserved. Environ Microbiol. 2004; 6: 716–25. [PubMed Abstract].
   Google Scholar
• Schmidt H, Bielaszewska M, Karch H. Transduction of enteric Escherichia coli isolates with a derivative of Shiga toxin 2-encoding bacteriophage phi3538 isolated from Escherichia coli O157:H7. Appl Environm Microbiol. 1999; 65: 3855–61.
   Web of Science ®Google Scholar
• Muniesa M, Blanco JE, De Simon M, Serra-Moreno R, Blanch AR, Jofre J. Diversity of stx2 converting bacteriophages induced from Shiga-toxin-producing Escherichia coli strains isolated from cattle. Microbiology. 2004; 150: 2959–71. [PubMed Abstract].
   Google Scholar
• Beutin L, Kaulfuss S, Herold S, Oswald E, Schmidt H. Genetic analysis of enteropathogenic and enterohemorrhagic Escherichia coli serogroup O103 strains by molecular typing of virulence and housekeeping genes and pulsed-field gel electrophoresis. J Clin Microbiol. 2005; 43: 1552–63. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Kappeli U, Hachler H, Giezendanner N, Beutin L, Stephan R. Human infections with non-O157 Shiga toxin-producing Escherichia coli, Switzerland, 2000–2009. Emerg Infect Dis. 2011; 17: 180–5. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Sekse C, Sunde M, Hopp P, Bruheim T, Cudjoe KS, Kvitle B, etal. Occurrence of potentially human-pathogenic Escherichia coli O103 in Norwegian sheep. Appl Environ Microbiol. 2013; 79: 7502–09. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Moore SC, Pettazzoni S, McMillan KE, Mellor GE, Barlow RS, Fegan N. Characterization of E. coli O103 isolates from Australian ruminants. 2015; Boston, MA: VTEC.
   Google Scholar
• Karama M, Johnson RP, Holtslander R, Gyles CL. Phenotypic and genotypic characterization of verotoxin-producing Escherichia coli O103:H2 isolates from cattle and humans. J Clin Microbiol. 2008; 46: 3569–75. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Prager R, Liesegang A, Voigt W, Rabsch W, Fruth A, Tschape H. Clonal diversity of Shiga toxin-producing Escherichia coli O103:H2/H(-) in Germany. Infect Genet Evol. 2002; 1: 265–75. [PubMed Abstract].
   Google Scholar
• Mariani-Kurkdjian P, Denamur E, Milon A, Picard B, Cave H, Lambert-Zechovsky N, etal. Identification of a clone of Escherichia coli O103:H2 as a potential agent of hemolytic-uremic syndrome in France. J Clin Microbiol. 1993; 31: 296–301. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Perelle S, Dilasser F, Grout J, Fach P. Detection of Escherichia coli serogroup O103 by real-time polymerase chain reaction. J Appl Microbiol. 2005; 98: 1162–68. [PubMed Abstract].
   Google Scholar
• Nielsen EM, Andersen MT. Detection and characterization of verocytotoxin-producing Escherichia coli by automated 5’ nuclease PCR assay. J Clin Microbiol. 2003; 41: 2884–93. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Madic J, Peytavin de Garam C, Vingadassalon N, Oswald E, Fach P, Jamet E, etal. Simplex and multiplex real-time PCR assays for the detection of flagellar (H-antigen) fliC alleles and intimin (eae) variants associated with enterohaemorrhagic Escherichia coli (EHEC) serotypes O26:H11, O103:H2, O111:H8, O145:H28 and O157:H7. J Appl Microbiol. 2010; 109: 1696–705. [PubMed Abstract].
   Google Scholar
• Delannoy S, Beutin L, Fach P. Use of clustered regularly interspaced short palindromic repeat sequence polymorphisms for specific detection of enterohemorrhagic Escherichia coli strains of serotypes O26:H11, O45:H2, O103:H2, O111:H8, O121:H19, O145:H28, and O157:H7 by real-time PCR. J Clin Microbiol. 2012; 50: 4035–40. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Schmieder R, Edwards R. Quality control and preprocessing of metagenomic datasets. Bioinformatics. 2011; 27: 863–64. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Ogura Y, Ooka T, Iguchi A, Toh H, Asadulghani M, Oshima K, etal. Comparative genomics reveal the mechanism of the parallel evolution of O157 and non-O157 enterohemorrhagic Escherichia coli. Proc Natl Acad Sci USA. 2009; 106: 17939–44. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Br J Pharmacol. 2012; 9: 357–9.
   Google Scholar
• DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, etal. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 2011; 43: 491–8. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Huson DH, Bryant D. Application of phylogenetic networks in evolutionary studies. Mol Biol Evol. 2006; 23: 254–67. [PubMed Abstract].
   Google Scholar
• Joensen KG, Scheutz F, Lund O, Hasman H, Kaas RS, Nielsen EM, etal. Real-time whole-genome sequencing for routine typing, surveillance, and outbreak detection of verotoxigenic Escherichia coli. J Clin Microbiol. 2014; 52: 1501–10. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Solheim HT, Sekse C, Urdahl AM, Wasteson Y, Nesse LL. Biofilm as an environment for dissemination of stx genes by transduction. Appl Environ Microbiol. 2013; 79: 896–900. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Sekse C, Muniesa M, Wasteson Y. Conserved Stx2 phages from Escherichia coli O103:H25 isolated from patients suffering from hemolytic uremic syndrome. Foodborne Path Dis. 2008; 5: 801–10. [PubMed Abstract].
   Google Scholar
• Serra-Moreno R, Acosta S, Hernalsteens JP, Jofre J, Muniesa M. Use of the lambda Red recombinase system to produce recombinant prophages carrying antibiotic resistance genes. BMC Mol Biol. 2006; 7: 31. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Allison HE, Sergeant MJ, James CE, Saunders JR, Smith DL, Sharp RJ, etal. Immunity profiles of wild-type and recombinant Shiga-like toxin-encoding bacteriophages and characterization of novel double lysogens. Infect Immun. 2003; 71: 3409–18. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Leopold SR, Magrini V, Holt NJ, Shaikh N, Mardis ER, Cagno J, etal. A precise reconstruction of the emergence and constrained radiations of Escherichia coli O157 portrayed by backbone concatenomic analysis. Proc Natl Acad Sci USA. 2009; 106: 8713–18. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Los JM, Los M, Wegrzyn A, Wegrzyn G. Altruism of Shiga toxin-producing Escherichia coli: recent hypothesis versus experimental results. Front Cell Infect Microbiol. 2012; 2: 166. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Public Health Agency of Sweden. Epidemiologisk årsrapport 2011. 2012. ISBN 978-91-86723-26-2.
   Google Scholar
• Orth D, Grif K, Khan AB, Naim A, Dierich MP, Wurzner R. The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome. Diagn Microbiol Infect Dis. 2007; 59: 235–42. [PubMed Abstract].
   Google Scholar
• Persson S, Olsen KE, Ethelberg S, Scheutz F. Subtyping method for Escherichia coli Shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations. J Clin Microbiol. 2007; 45: 2020–24. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Mauro SA, Koudelka GB. Shiga toxin: expression, distribution, and its role in the environment. Toxins. 2011; 3: 608–25. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar